Ocular Findings Associated with Hypoparathyroidism

ArticleAçık Erişim

Özet

Purpose: To determine the corneal and retinal changes associated with serum calcium, phosphorus and parathyroid hormone (PTH) levels in patients with hypoparathyroidism. Methods: Patients who were under follow-up for hypoparathyroidism in the endocrinology department were included in the study. All participants underwent a complete ophthalmological examination. Moreover, central corneal thickness (CCT), anterior chamber depth (ACD), retinal nerve fiber layer (RNFL) thickness, ganglion cell layer (GCL) thickness were recorded. Serum biochemical parameters were recorded. Results: In a total of 75 patients (35 in the hypoparathyroidism group and 40 in the healthy control group) were included in this study. Central corneal thickness (519.95 ± 33.21 vs. 539.10 ± 32.96, p: 0.001) and RNFL (105.10 ± 11.89 vs. 113.56 ± 9.54, p: 0.005) were significantly thinner and ACD was significantly deeper in the hypoparathyroidism group. Conclusion: We determined thinner CCT and RNFL values in patients with hypoparathyroidism related to serum calcium levels together with a significant deepness in ACD. © 2020 Taylor & Francis Group, LLC.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/13202Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorTaşlı, Nurdan Gamze
dc.contributor.authorAkbaş, Emin Murat
dc.date.accessioned2026-10-18T20:28:02.539357113Z
dc.date.available2026-10-18T20:28:02.539357113Z
dc.date.issued2021
dc.description.abstractPurpose: To determine the corneal and retinal changes associated with serum calcium, phosphorus and parathyroid hormone (PTH) levels in patients with hypoparathyroidism. Methods: Patients who were under follow-up for hypoparathyroidism in the endocrinology department were included in the study. All participants underwent a complete ophthalmological examination. Moreover, central corneal thickness (CCT), anterior chamber depth (ACD), retinal nerve fiber layer (RNFL) thickness, ganglion cell layer (GCL) thickness were recorded. Serum biochemical parameters were recorded. Results: In a total of 75 patients (35 in the hypoparathyroidism group and 40 in the healthy control group) were included in this study. Central corneal thickness (519.95 ± 33.21 vs. 539.10 ± 32.96, p: 0.001) and RNFL (105.10 ± 11.89 vs. 113.56 ± 9.54, p: 0.005) were significantly thinner and ACD was significantly deeper in the hypoparathyroidism group. Conclusion: We determined thinner CCT and RNFL values in patients with hypoparathyroidism related to serum calcium levels together with a significant deepness in ACD. © 2020 Taylor & Francis Group, LLC.
dc.identifier.doi10.1080/09273948.2020.1735451
dc.identifier.endpage1291
dc.identifier.issn0927-3948
dc.identifier.issue7-8
dc.identifier.pmid32267183
dc.identifier.scopus2-s2.0-85083573864
dc.identifier.startpage1287
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/13202
dc.identifier.volume29
dc.language.isoen
dc.publisherTaylor and Francis Ltd.
dc.relation.ispartofOcular Immunology and Inflammation
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectcataract
dc.subjectHypoparathyroidism
dc.subjectocular findings
dc.subjectretinal nerve fiber layer
dc.subjectvitamin D
dc.subjectAdult
dc.subjectAnterior Chamber
dc.subjectCalcium
dc.subjectCorneal Diseases
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectNerve Fibers
dc.subjectParathyroid Hormone
dc.subjectPhosphorus
dc.subjectRetinal Diseases
dc.subjectRetinal Ganglion Cells
dc.subjectTomography, Optical Coherence
dc.subjectVisual Acuity
dc.subjectalkaline phosphatase
dc.subjectcalcitriol
dc.subjectcalcium carbonate
dc.subjectcreatinine
dc.subjectgluconate calcium
dc.subjectmagnesium
dc.subjectthyrotropin
dc.subjectanterior eye chamber depth
dc.subjectArticle
dc.subjectbest corrected visual acuity
dc.titleOcular Findings Associated with Hypoparathyroidism
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus4
rdl.departmentDepartment of Ophthalmology, College of Medicine, Erzincan Binali Yıldırım University Hospital, Erzincan, Turkey. | Department of Internal Medicine, Division of Endocrinology, College of Medicine, Erzincan Binali Yıldırım University Hospital, Erzincan, Turkey.
rdl.source.indexSCOPUS
rdl.source.indexPUBMED